Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Sales (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Sales for 9 consecutive years, with 1040.0% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 4773.0% to 1040.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1204.55% through Dec 2025, down 60308.0% year-over-year, with the annual reading at 1204.55% for FY2025, 60308.0% down from the prior year.
  • Return on Sales for Q4 2025 was 1040.0% at Creative Medical Technology Holdings, up from 1180.69% in the prior quarter.
  • The five-year high for Return on Sales was 17.86% in Q3 2022, with the low at 1180.69% in Q3 2025.
  • Average Return on Sales over 5 years is 419.59%, with a median of 266.42% recorded in 2021.
  • The sharpest move saw Return on Sales surged 215364bps in 2021, then crashed -95334bps in 2025.
  • Over 5 years, Return on Sales stood at 57.2% in 2021, then tumbled by -484bps to 334.18% in 2022, then crashed by -67bps to 559.52% in 2023, then crashed by -77bps to 992.27% in 2024, then fell by -5bps to 1040.0% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1040.0%, 1180.69%, and 1148.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.